文献: 糖尿病等慢性疾病的综合管理-环境污染与2型糖尿病关系篇

References for Integrative Medical Management of Diabetes and Other Chronic Diseases

“糖尿病等慢性疾病的综合管理-必需金属及有毒金属与2型糖尿病关系篇”文献

文献 (References)

  1. Rate of diabetes in China “explosive” [Internet]. [cited 2019 Dec 7]. Available from: https://www.who.int/china/news/detail/06-04-2016-rate-of-diabetes-in-china-explosive-
  2. CDC Press Releases [Internet]. CDC. 2016 [cited 2019 Dec 7]. Available from: https://www.cdc.gov/media/releases/2017/p0718-diabetes-report.html
  3. Kazi TG, Afridi HI, Kazi N, Jamali MK, Arain MB, Jalbani N, Kandhro GA. Copper, chromium, manganese, iron, nickel, and zinc levels in biological samples of diabetes mellitus patients. Biol Trace Elem Res. 2008 Apr;122(1):1–18.
  4. Simsek A, Aykut O. Evaluation of the microelement profile of Turkish hazelnut (Corylus avellana L.) varieties for human nutrition and health. Int J Food Sci Nutr. 2007 Dec;58(8):677–88.
  5. Soetan KO, Olaiya CO, Oyewole OE. The importance of mineral elements for humans, domestic animals and plants: A review. :23.
  6. Grivetti LE, Ogle BM. Value of traditional foods in meeting macro- and micronutrient needs: the wild plant connection. Nutr Res Rev. 2000 Jun;13(1):31–46.
  7. Khan AR, Awan FR. Metals in the pathogenesis of type 2 diabetes. J Diabetes Metab Disord. 2014 Jan 8;13:16.
  8. Fraga CG. Relevance, essentiality and toxicity of trace elements in human health. Mol Aspects Med. 2005 Oct;26(4–5):235–44.
  9. McCall KA, Huang C, Fierke CA. Function and mechanism of zinc metalloenzymes. J Nutr. 2000;130(5S Suppl):1437S-46S.
  10. Lu Y, Yeung N, Sieracki N, Marshall NM. Design of functional metalloproteins. Nature. 2009 Aug 13;460(7257):855–62.
  11. Lutsenko S, Barnes NL, Bartee MY, Dmitriev OY. Function and regulation of human copper-transporting ATPases. Physiol Rev. 2007 Jul;87(3):1011–46.
  12. Guidotti TL, McNamara J, Moses MS. The interpretation of trace element analysis in body fluids. Indian J Med Res. 2008 Oct;128(4):524–32.
  13. Stechmiller JK. Understanding the role of nutrition and wound healing. Nutr Clin Pract Off Publ Am Soc Parenter Enter Nutr. 2010 Feb;25(1):61–8.
  14. Wish JB. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol CJASN. 2006 Sep;1 Suppl 1:S4-8.
  15. Kundu D, Roy A, Mandal T, Bandyopadhyay U, Ghosh E, Ray D. Relation of iron stores to oxidative stress in type 2 diabetes. Niger J Clin Pract. 2013 Jan 1;16(1):100.
  16. McClain DA, Abraham D, Rogers J, Brady R, Gault P, Ajioka R, Kushner JP. High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis. Diabetologia. 2006 Jul;49(7):1661–9.
  17. Raj S, Rajan GV. Correlation between elevated serum ferritin and HbA1c in type 2 diabetes mellitus. Int J Res Med Sci. 2017 Jan 26;1(1):12–5.
  18. Rajpathak S, Ma J, Manson J, Willett WC, Hu FB. Iron intake and the risk of type 2 diabetes in women: a prospective cohort study. Diabetes Care. 2006 Jun;29(6):1370–6.
  19. Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Dawkins FW, Acton RT, Harris EL, Gordeuk VR, Leiendecker-Foster C, Speechley M, Snively BM, Holup JL, Thomson E, Sholinsky P, Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med. 2005 Apr 28;352(17):1769–78.
  20. Acton RT, Barton JC, Passmore LV, Adams PC, Speechley MR, Dawkins FW, Sholinsky P, Reboussin DM, McLaren GD, Harris EL, Bent TC, Vogt TM, Castro O. Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the Hemochromatosis and Iron Overload Screening (HEIRS) study. Diabetes Care. 2006 Sep;29(9):2084–9.
  21. Worwood M. Serum transferrin receptor assays and their application. Ann Clin Biochem. 2002 May;39(Pt 3):221–30.
  22. Jiang R, Manson JE, Meigs JB, Ma J, Rifai N, Hu FB. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA. 2004 Feb 11;291(6):711–7.
  23. Jehn M, Clark JM, Guallar E. Serum Ferritin and Risk of the Metabolic Syndrome in U.S. Adults. Diabetes Care. 2004 Oct 1;27(10):2422–8.
  24. Fernández-Real JM, Peñarroja G, Castro A, García-Bragado F, Hernández-Aguado I, Ricart W. Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function. Diabetes. 2002 Apr;51(4):1000–4.
  25. Papanikolaou G, Pantopoulos K. Iron metabolism and toxicity. Toxicol Appl Pharmacol. 2005 Jan 15;202(2):199–211.
  26. Lee D-H, Liu DY, Jacobs DR, Shin H-R, Song K, Lee I-K, Kim B, Hider RC. Common presence of non-transferrin-bound iron among patients with type 2 diabetes. Diabetes Care. 2006 May;29(5):1090–5.
  27. Sharifi F, Nasab NM, Zadeh HJ. Elevated serum ferritin concentrations in prediabetic subjects. Diab Vasc Dis Res. 2008 Mar;5(1):15–8.
  28. Kim C-H, Kim H-K, Bae SJ, Park J-Y, Lee K-U. Association of elevated serum ferritin concentration with insulin resistance and impaired glucose metabolism in Korean men and women. Metabolism. 2011 Mar;60(3):414–20.
  29. Forouhi NG, Harding AH, Allison M, Sandhu MS, Welch A, Luben R, Bingham S, Khaw KT, Wareham NJ. Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study. Diabetologia. 2007 May;50(5):949–56.
  30. Rajpathak SN, Wylie-Rosett J, Gunter MJ, Negassa A, Kabat GC, Rohan TE, Crandall J, Diabetes Prevention Program (DPP) Research Group. Biomarkers of body iron stores and risk of developing type 2 diabetes. Diabetes Obes Metab. 2009 May;11(5):472–9.
  31. Lopez-Ridaura R, Willett WC, Rimm EB, Liu S, Stampfer MJ, Manson JE, Hu FB. Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care. 2004 Jan;27(1):134–40.
  32. Magnesium: Reversing Disease: MD Jd Levy: 9780998312408: Amazon.com: Books [Internet]. [cited 2019 Dec 10]. Available from: https://www.amazon.com/Magnesium-Reversing-MD-Jd-Levy/dp/0998312401/ref=sr_1_1?crid=DBLHI5CRJUAA&keywords=magnesium+levy&qid=1575986348&sprefix=magnesi%2Caps%2C215&sr=8-1
  33. Swaminathan R. Magnesium metabolism and its disorders. Clin Biochem Rev. 2003 May;24(2):47–66.
  34. Kostov K. Effects of Magnesium Deficiency on Mechanisms of Insulin Resistance in Type 2 Diabetes: Focusing on the Processes of Insulin Secretion and Signaling. Int J Mol Sci. 2019 Mar 18;20(6).
  35. de Valk HW. Magnesium in diabetes mellitus. Neth J Med. 1999 Apr;54(4):139–46.
  36. Afridi HI, Kazi TG, Kazi N, Jamali MK, Arain MB, Jalbani N, Sarfaraz RA, Shah A, Kandhro GA, Shah AQ, Baig JA. Potassium, calcium, magnesium, and sodium levels in biological samples of hypertensive and nonhypertensive diabetes mellitus patients. Biol Trace Elem Res. 2008 Sep;124(3):206–24.
  37. Mooren FC, Krüger K, Völker K, Golf SW, Wadepuhl M, Kraus A. Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects – a double-blind, placebo-controlled, randomized trial. Diabetes Obes Metab. 2011 Mar;13(3):281–4.
  38. Zghoul N, Alam-Eldin N, Mak IT, Silver B, Weglicki WB. Hypomagnesemia in diabetes patients: comparison of serum and intracellular measurement of responses to magnesium supplementation and its role in inflammation. Diabetes Metab Syndr Obes Targets Ther. 2018;11:389–400.
  39. Schutten JC, Gomes-Neto AW, Navis G, Gansevoort RT, Dullaart RPF, Kootstra-Ros JE, Danel RM, Goorman F, Gans ROB, de Borst MH, Jeyarajah EJ, Shalaurova I, Otvos JD, Connelly MA, Bakker SJL. Lower Plasma Magnesium, Measured by Nuclear Magnetic Resonance Spectroscopy, is Associated with Increased Risk of Developing Type 2 Diabetes Mellitus in Women: Results from a Dutch Prospective Cohort Study. J Clin Med. 2019 01;8(2).
  40. Zhang X, Xia J, Del Gobbo LC, Hruby A, Dai Q, Song Y. Serum magnesium concentrations and all-cause, cardiovascular, and cancer mortality among U.S. adults: Results from the NHANES I Epidemiologic Follow-up Study. Clin Nutr Edinb Scotl. 2018;37(5):1541–9.
  41. Paolisso G, Barbagallo M. Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium. Am J Hypertens. 1997 Mar;10(3):346–55.
  42. Moctezuma-Velázquez C, Gómez-Sámano MÁ, Cajas-Sánchez MB, Reyes-Molina DL, Galindo-Guzmán M, Meza-Arana C-E, Cuevas-Ramos D, Gómez-Pérez FJ, Gulias-Herrero A. High Dietary Magnesium Intake is Significantly and Independently Associated with Higher Insulin Sensitivity in a Mexican-Mestizo Population: A Brief Cross-Sectional Report. Rev Investig Clin Organo Hosp Enfermedades Nutr. 2017 Feb;69(1):40–6.
  43. Shahbah D, Hassan T, Morsy S, Saadany HE, Fathy M, Al-Ghobashy A, Elsamad N, Emam A, Elhewala A, Ibrahim B, Gebaly SE, Sayed HE, Ahmed H. Oral magnesium supplementation improves glycemic control and lipid profile in children with type 1 diabetes and hypomagnesaemia. Medicine (Baltimore). 2017 Mar;96(11):e6352.
  44. Verma H, Garg R. Effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors: a systematic review and meta-analysis. J Hum Nutr Diet Off J Br Diet Assoc. 2017;30(5):621–33.
  45. Konishi K, Wada K, Tamura T, Tsuji M, Kawachi T, Nagata C. Dietary magnesium intake and the risk of diabetes in the Japanese community: results from the Takayama study. Eur J Nutr. 2017 Mar;56(2):767–74.
  46. Hruby A, Guasch-Ferré M, Bhupathiraju SN, Manson JE, Willett WC, McKeown NM, Hu FB. Magnesium Intake, Quality of Carbohydrates, and Risk of Type 2 Diabetes: Results From Three U.S. Cohorts. Diabetes Care. 2017;40(12):1695–702.
  47. Gant CM, Soedamah-Muthu SS, Binnenmars SH, Bakker SJL, Navis G, Laverman GD. Higher Dietary Magnesium Intake and Higher Magnesium Status Are Associated with Lower Prevalence of Coronary Heart Disease in Patients with Type 2 Diabetes. Nutrients. 2018 Mar 5;10(3).
  48. Richter EA, Hargreaves M. Exercise, GLUT4, and skeletal muscle glucose uptake. Physiol Rev. 2013 Jul;93(3):993–1017.
  49. ELDerawi WA, Naser IA, Taleb MH, Abutair AS. The Effects of Oral Magnesium Supplementation on Glycemic Response among Type 2 Diabetes Patients. Nutrients. 2018 Dec 26;11(1).
  50. Morakinyo AO, Samuel TA, Adekunbi DA. Magnesium upregulates insulin receptor and glucose transporter-4 in streptozotocin-nicotinamide-induced type-2 diabetic rats. Endocr Regul. 2018 Jan 1;52(1):6–16.
  51. Takaya J, Higashino H, Kobayashi Y. Intracellular magnesium and insulin resistance. Magnes Res. 2004 Jun;17(2):126–36.
  52. Guerrero-Romero F, Rodríguez-Morán M. Magnesium improves the beta-cell function to compensate variation of insulin sensitivity: double-blind, randomized clinical trial. Eur J Clin Invest. 2011 Apr;41(4):405–10.
  53. Rodríguez-Morán M, Guerrero-Romero F. Insulin secretion is decreased in non-diabetic individuals with hypomagnesaemia. Diabetes Metab Res Rev. 2011 Sep;27(6):590–6.
  54. Gommers LMM, Hoenderop JGJ, Bindels RJM, de Baaij JHF. Hypomagnesemia in Type 2 Diabetes: A Vicious Circle? Diabetes. 2016 Jan;65(1):3–13.
  55. Bardicef M, Bardicef O, Sorokin Y, Altura BM, Altura BT, Cotton DB, Resnick LM. Extracellular and intracellular magnesium depletion in pregnancy and gestational diabetes. Am J Obstet Gynecol. 1995 Mar;172(3):1009–13.
  56. Maktabi M, Jamilian M, Amirani E, Chamani M, Asemi Z. The effects of magnesium and vitamin E co-supplementation on parameters of glucose homeostasis and lipid profiles in patients with gestational diabetes. Lipids Health Dis. 2018 Jul 20;17(1):163.
  57. Orbea A, Ortiz-Zarragoitia M, Solé M, Porte C, Cajaraville MP. Antioxidant enzymes and peroxisome proliferation in relation to contaminant body burdens of PAHs and PCBs in bivalve molluscs, crabs and fish from the Urdaibai and Plentzia estuaries (Bay of Biscay). Aquat Toxicol Amst Neth. 2002 Jul;58(1–2):75–98.
  58. Serdar MA, Bakir F, Haşimi A, Celik T, Akin O, Kenar L, Aykut O, Yildirimkaya M. Trace and toxic element patterns in nonsmoker patients with noninsulin-dependent diabetes mellitus, impaired glucose tolerance, and fasting glucose. Int J Diabetes Dev Ctries. 2009 Jan;29(1):35–40.
  59. Rico H, Gómez-Raso N, Revilla M, Hernández ER, Seco C, Páez E, Crespo E. Effects on bone loss of manganese alone or with copper supplement in ovariectomized rats. A morphometric and densitomeric study. Eur J Obstet Gynecol Reprod Biol. 2000 May;90(1):97–101.
  60. Forte G, Bocca B, Peruzzu A, Tolu F, Asara Y, Farace C, Oggiano R, Madeddu R. Blood metals concentration in type 1 and type 2 diabetics. Biol Trace Elem Res. 2013 Dec;156(1–3):79–90.
  61. Olivares M, Araya M, Uauy R. Copper homeostasis in infant nutrition: deficit and excess. J Pediatr Gastroenterol Nutr. 2000 Aug;31(2):102–11.
  62. [PDF] Reduction in Cholesterol and Triglyceride Serum Levels Following Low-Level Laser Irradiation: A Noncontrolled, Nonrandomized Pilot Study | Semantic Scholar [Internet]. [cited 2019 Dec 10]. Available from: https://www.semanticscholar.org/paper/Reduction-in-Cholesterol-and-Triglyceride-Serum-A-Jackson-Roche/dcfcfa5862c859099bccea4968d4e482274d77de
  63. Kako K, Takehara A, Arai H, Onodera T, Takahashi Y, Hanagata H, Ogra Y, Takagi H, Kodama H, Suzuki KT, Munekata E, Fukamizu A. A selective requirement for copper-dependent activation of cytochrome c oxidase by Cox17p. Biochem Biophys Res Commun. 2004 Nov 26;324(4):1379–85.
  64. Lin C-C, Huang J-F, Tsai L-Y, Huang Y-L. Selenium, iron, copper, and zinc levels and copper-to-zinc ratios in serum of patients at different stages of viral hepatic diseases. Biol Trace Elem Res. 2006 Jan;109(1):15–24.
  65. Quilliot D, Dousset B, Guerci B, Dubois F, Drouin P, Ziegler O. Evidence that diabetes mellitus favors impaired metabolism of zinc, copper, and selenium in chronic pancreatitis. Pancreas. 2001 Apr;22(3):299–306.
  66. Klevay LM. Cardiovascular disease from copper deficiency–a history. J Nutr. 2000;130(2S Suppl):489S-492S.
  67. Chwiej J, Winiarski W, Ciarach M, Janeczko K, Lankosz M, Rickers K, Setkowicz Z. The role of trace elements in the pathogenesis and progress of pilocarpine-induced epileptic seizures. J Biol Inorg Chem JBIC Publ Soc Biol Inorg Chem. 2008 Nov;13(8):1267–74.
  68. Eaton JW, Qian M. Interactions of copper with glycated proteins: possible involvement in the etiology of diabetic neuropathy. Mol Cell Biochem. 2002 Jun;234–235(1–2):135–42.
  69. John E, Laskow TC, Buchser WJ, Pitt BR, Basse PH, Butterfield LH, Kalinski P, Lotze MT. Zinc in innate and adaptive tumor immunity. J Transl Med. 2010 Nov 18;8:118.
  70. Zheng H, Blat D, Fridkin M. Novel neuroprotective neurotrophic NAP analogs targeting metal toxicity and oxidative stress: potential candidates for the control of neurodegenerative diseases. J Neural Transm Suppl. 2006;(71):163–72.
  71. Karamouzis MV, Gorgoulis VG, Papavassiliou AG. Transcription factors and neoplasia: vistas in novel drug design. Clin Cancer Res Off J Am Assoc Cancer Res. 2002 May;8(5):949–61.
  72. Jansen J, Karges W, Rink L. Zinc and diabetes–clinical links and molecular mechanisms. J Nutr Biochem. 2009 Jun;20(6):399–417.
  73. Dröge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002 Jan;82(1):47–95.
  74. Wapnir RA. Zinc deficiency, malnutrition and the gastrointestinal tract. J Nutr. 2000;130(5S Suppl):1388S-92S.
  75. Tudan C, Weber FX, Levine KE. The status of trace elements analysis in biological systems. Bioanalysis. 2011 Aug;3(15):1695–7.
  76. O’Connell BS. Select Vitamins and Minerals in the Management of Diabetes. Diabetes Spectr. 2001 Aug 1;14(3):133–48.
  77. Qiao W, Peng Z, Wang Z, Wei J, Zhou A. Chromium improves glucose uptake and metabolism through upregulating the mRNA levels of IR, GLUT4, GS, and UCP3 in skeletal muscle cells. Biol Trace Elem Res. 2009 Nov;131(2):133–42.
  78. Wiernsperger N, Rapin J. Trace elements in glucometabolic disorders: an update. Diabetol Metab Syndr. 2010 Dec 19;2(1):70.
  79. Lai M-H, Chen Y-Y, Cheng H-H. Chromium yeast supplementation improves fasting plasma glucose and LDL-cholesterol in streptozotocin-induced diabetic rats. Int J Vitam Nutr Res Int Z Vitam- Ernahrungsforschung J Int Vitaminol Nutr. 2006 Nov;76(6):391–7.
  80. Chen YW, Yang CY, Huang CF, Hung DZ, Leung YM, Liu SH. Heavy metals, islet function and diabetes development. Islets. 2009 Dec;1(3):169–76.
  81. Valko M, Morris H, Cronin MTD. Metals, toxicity and oxidative stress. Curr Med Chem. 2005;12(10):1161–208.
  82. Chiu A, Katz AJ, Beaubier J, Chiu N, Shi X. Genetic and cellular mechanisms in chromium and nickel carcinogenesis considering epidemiologic findings. Mol Cell Biochem. 2004 Jan;255(1–2):181–94.
  83. Yabe J, Nakayama SMM, Ikenaka Y, Muzandu K, Ishizuka M, Umemura T. Uptake of lead, cadmium, and other metals in the liver and kidneys of cattle near a lead-zinc mine in Kabwe, Zambia. Environ Toxicol Chem. 2011 Aug;30(8):1892–7.
  84. Afridi HI, Kazi TG, Kazi N, Jamali MK, Arain MB, Jalbani N, Baig JA, Sarfraz RA. Evaluation of status of toxic metals in biological samples of diabetes mellitus patients. Diabetes Res Clin Pract. 2008 May;80(2):280–8.
  85. Martinez-Finley EJ, Chakraborty S, Fretham SJB, Aschner M. Cellular transport and homeostasis of essential and nonessential metals. Met Integr Biometal Sci. 2012 Jul;4(7):593–605.
  86. Environmental Exposure to Lead and Progression of Chronic Renal Diseases: A Four-Year Prospective Longitudinal Study | American Society of Nephrology [Internet]. [cited 2019 Dec 10]. Available from: https://jasn.asnjournals.org/content/15/4/1016
  87. Kazi TG, Jalbani N, Kazi N, Arain MB, Jamali MK, Afridi HI, Kandhro GA, Sarfraz RA, Shah AQ, Ansari R. Estimation of toxic metals in scalp hair samples of chronic kidney patients. Biol Trace Elem Res. 2009 Jan;127(1):16–27.
  88. Beyersmann D, Hartwig A. Carcinogenic metal compounds: recent insight into molecular and cellular mechanisms. Arch Toxicol. 2008 Aug;82(8):493–512.
  89. Aoshima K. Itai-itai disease: Lessons from the investigations of environmental epidemiology conducted in the 1970’s, with special reference to the studies of the Toyama Institute of Health. Nihon Eiseigaku Zasshi Jpn J Hyg. 2017;72(3):149–58.
  90. Arsenic [Internet]. [cited 2019 Oct 24]. Available from: https://www.who.int/news-room/fact-sheets/detail/arsenic
  91. Pershagen G. The carcinogenicity of arsenic. Environ Health Perspect. 1981 Aug;40:93–100.
  92. Arsenic Exposure and the Induction of Human Cancers [Internet]. [cited 2019 Dec 10]. Available from: https://www.hindawi.com/journals/jt/2011/431287/
  93. Sohn E. Contamination: The toxic side of rice. Nature. 2014 Oct;514(7524):S62–3.
  94. Carmean CM, Seino S. Braving the Element: Pancreatic β-Cell Dysfunction and Adaptation in Response to Arsenic Exposure. Front Endocrinol. 2019;10:344.
  95. Fan Y, Zhu T, Li M, He J, Huang R. Heavy Metal Contamination in Soil and Brown Rice and Human Health Risk Assessment near Three Mining Areas in Central China. J Healthc Eng. 2017;2017:4124302.
  96. Pizzorno J. Is the Diabetes Epidemic Primarily Due to Toxins? Integr Med Clin J. 2016 Aug;15(4):8–17.
  97. Das KK, Das SN, Dhundasi SA. Nickel, its adverse health effects & oxidative stress. Indian J Med Res. 2008 Oct;128(4):412–25.
  98. Kubrak OI, Husak VV, Rovenko BM, Poigner H, Mazepa MA, Kriews M, Abele D, Lushchak VI. Tissue specificity in nickel uptake and induction of oxidative stress in kidney and spleen of goldfish Carassius auratus, exposed to waterborne nickel. Aquat Toxicol Amst Neth. 2012 Aug 15;118–119:88–96.